SOCIETY FOR BRAIN MAPPING AND THERAPEUTICS

SOCIETY FOR BRAIN MAPPING AND THERAPEUTICS

BREAKING BOUNDARIES OF SCIENCE, TECHNOLOGY, MEDICINE, ART & HEALTHCARE POLICY

Session Chair: Margaret Fahnestock, PhD

3:30 – 3:45 PM
Early Diagnosis for Alzheimer’s Disease using Retinal Thinning/Biomarkers: Future Partners in Care

Amy Dee Pruszenski, OD

Visual Victory Training, PLLC, and Director of Medical Education for Neuro-Optometric Rehabilitation Association, USA

3:45 – 4:00 PM
Reaching Populations at risk of Alzheimer’s Dementia Related Diseases: Delivery and Implementation

David Ndetei PhD, DSc

Professor of Psychiatry, University of Nairobi; Founding Director of Africa Mental Health Foundation, Kenya

4:00 – 4:15 PM
Chlamydia Pneumoniae Infection and Associated NLRP3 Inflammasome Activation in Alzheimer’s Disease Retina

Bhakta Prasad Gaire, PhD

Project Scientist, Department of Neurosurgery, Cedars-Sinai Medical Center, Los Angeles, CA, USA

4:15 – 4:30 PM
Long-Covid, Neurovascular and Cardiovascular Inflammation, Cognitive Deficits and Alzheimer Risk

Sally A Frautschy PhD

Professor of Neurology and Medicine, UCLA; GRECC, GLA-VA, California, USA

4:30 – 4:45 PM
Poverty Brings Earlier Dementia from Unknown GxE Interactions in the Socio-economic strata

Caleb Ellicott Finch, PhD

ARCO and Kieschnick Professor in Neurogerontology, University of Southern California, USA

4:45 – 5:00 PM
Q & A

Session Chairs

March 15 @ 15:30
15:30 — 17:00 (1h 30′)

Room 409 B

Alzheimer’s Disease and Dementia

Add